ANKHD1 Antikörper (AA 1901-2000) (FITC)
Kurzübersicht für ANKHD1 Antikörper (AA 1901-2000) (FITC) (ABIN758538)
Target
Alle ANKHD1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1901-2000
-
Homologie
- Human,Dog,Cow,Sheep,Pig,Horse
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human ANKHD1
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- ANKHD1 (Ankyrin Repeat and KH Domain Containing 1 (ANKHD1))
-
Andere Bezeichnung
- ANKHD1
-
Hintergrund
-
Synonyms: ANKH1_HUMAN, ANKHD 1, ANKHD1, Ankyrin repeat and KH domain containing 1, Ankyrin repeat and KH domain containing protein 1, Ankyrin repeat and KH domain-containing protein 1, HIV-1 Vpr-binding ankyrin repeat protein, HIV1 Vpr binding ankyrin repeat protein, hMASK, MASK, Multiple ankyrin repeats single KH domain, Multiple ankyrin repeats single KH domain homolog, VBARP.
Background: May play a role as a scaffolding protein that may be associated with the abnormal phenotype of leukemia cells. Isoform 2 may possess an antiapoptotic effect and protect cells during normal cell survival through its regulation of caspases.
-
Gen-ID
- 54882
Target
-